J. Kevin Buchi
CIK: 0001209726
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Sep 17, 2026AMRX
Amneal Pharmaceuticals, Inc.
Gift(G)Direct20.4K shares- - Sep 11, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct20.4K shares at avg. $14.45$295K - Aug 11, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Indirect168.6K shares at avg. $17.18$2.9M - May 7, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct34.8K shares- - May 6, 2026AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
19.8K shares- - Dec 1, 2025BNTC
Benitec Biopharma Inc.
Award(A)DirectOptions (right to buy)
35K shares- - May 6, 2025AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
34.8K shares- - May 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct40.3K shares- - Mar 12, 2025BNTC
Benitec Biopharma Inc.
Gift(G)Indirect103.6K shares- - Mar 12, 2025BNTC
Benitec Biopharma Inc.
Gift(G)Direct103.6K shares- - Mar 10, 2025AMRX
Amneal Pharmaceuticals, Inc.
Gift(G)Direct262.1K shares- - Feb 27, 2025BNTC
Benitec Biopharma Inc.
Exercise(M)Direct51.8K shares at avg. $3.86$200K - Dec 9, 2024BNTC
Benitec Biopharma Inc.
Award(A)DirectOptions (right to buy)
35K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 17, 2026 |  AMRX Amneal Pharmaceuticals, Inc. | Gift(G) | 20,445 | - | $0 | Direct |
| Sep 11, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 20,445 | $14.45 | $295,430 | Direct |
| Aug 11, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 168,573 | $17.18 | $2,896,084 | Indirect |
| May 7, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 34,819 | - | $0 | Direct |
| May 6, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 19,824 | - | - | Direct |
| Dec 1, 2025 |  BNTC Benitec Biopharma Inc. | Award(A) Options (right to buy) | 35,000 | - | - | Direct |
| May 6, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 34,819 | - | - | Direct |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 40,258 | - | - | Direct |
| Mar 12, 2025 | BNTC Benitec Biopharma Inc. | Gift(G) | 103,626 | - | - | Indirect |
| Mar 12, 2025 | BNTC Benitec Biopharma Inc. | Gift(G) | 103,626 | - | - | Direct |
| Mar 10, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Gift(G) | 262,072 | - | - | Direct |
| Feb 27, 2025 | BNTC Benitec Biopharma Inc. | Exercise(M) | 51,813 | $3.86 | $199,998 | Direct |
| Dec 9, 2024 | BNTC Benitec Biopharma Inc. | Award(A) Options (right to buy) | 35,000 | - | - | Direct |
1-13 of 13 transactions
About BUCHI J KEVIN
BUCHI J KEVIN (SEC CIK 0001209726) files insider reports with the SEC as Director of Amneal Pharmaceuticals, Inc. (AMRX) and Director of Benitec Biopharma Inc. (BNTC).
Signal8 holds 10 ownership filings by BUCHI J KEVIN, all Form 4s, filed between Dec 11, 2024 and Sep 21, 2026. Those filings report 13 transactions, from Dec 9, 2024 to Sep 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BUCHI J KEVIN's filings is in BRIDGEWATER, NJ.
Recent filings by BUCHI J KEVIN
- Sep 17, 2026: Gift of AMRX shares (Form 4, code G).
- Sep 11, 2026: Option exercise of AMRX shares (Form 4, code M).
- Aug 11, 2026: Option exercise of AMRX shares (Form 4, code M).
- May 7, 2026: Option exercise of AMRX shares (Form 4, code M).
- May 6, 2026: Grant or award of AMRX derivative securities (Form 4, code A).
Other insiders filing for Amneal Pharmaceuticals, Inc. (AMRX)
- BOYER ANDREW S, Executive Vice President
- Kiely John, Director
- Shah Nikita, Executive Vice President
- Daly Jason B., EVP, Chief Legal Officer
- Patel Tushar Bhikhubhai, 10% Owner
- Patel Chintu, Co-CEO